Offices Closed on Friday, July 4, 2025
All Texas Retina offices will be closed on Friday, July 4, 2025, in recognition of the Independence Day holiday and will reopen on Monday, July 7. We wish everyone a safe and
read more
June is Fireworks Eye Safety Awareness Month
Summer is here, and for many that means outdoor celebrations that include fireworks, especially around the 4th of July. Unfortunately, this also means an increase in eye injuries. Here are a few
read more
Dr. Abbey Presented Study Results of Two Investigational Wet AMD Treatments at Clinical Trials Summit
This past weekend, Texas Retina’s Director of Clinical Research for Dallas Ashkan M. Abbey, MD, led two presentations at the annual Clinical Trials at the Summit (CTS) meeting in Las Vegas, which
read more
Initial Results of Phase Ib LOTUS Clinical Trial on Potential New Diabetic Macular Edema Treatment Released
On June 9, 2025, Eluminex Biosciences Limited, a clinical-stage protein therapeutics company, announced positive topline safety, tolerability, and pharmacodynamic data from the multicenter LOTUS Part 1 clinical trial of EB-105 in patients
read more
11 Tips to Protect Men’s Eye Health
June is Men’s Health Month. It was established to help bring awareness to health issues men face and to encourage them to take charge of their health. A number of retinal diseases can affect
read more
Dr. Wang Featured in New Retina Radio Podcast
Texas Retina’s Robert C. Wang, MD, was interviewed about his presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting for an episode of the New Retina Radio podcast
read more
Can Ozempic Affect Your Eyes or Vision?
Initially approved by the U.S. Food and Drug Administration (FDA) to help control blood sugar and treat type 2 diabetes, semaglutide (brand names Ozempic, Wegovy and Rybelsus) has also emerged as a
read more
Texas Retina Associates Participating in Phase III Clinical Trial for Choroidal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina is participating in the Phase III AU-011 clinical trial (CoMpass) for treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences,
read more
May is Ocular Melanoma Awareness Month
Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina, we have been caring for ocular melanoma
read more
Dr. Abbey Shares 36-Month Results of Pegcetacoplan Treatment for Geographic Atrophy in AMD
On behalf of the investigators for the OAKS, DERBY, and GALE clinical trials, Texas Retina’s Director of Clinical Research for Dallas, Ashkan Abbey, MD, co-authored an article titled, “Pegcetacoplan Treatment for Geographic
read more